March 1, 2022
The Ministry of Health, Labor and Welfare (MHLW) said on February 25 that it is making seven drugs (APIs) eligible for health coverage for their use in fertility treatments, including Sumitomo Dainippon Pharma’s Metgluco (metformin) and Novartis Pharma’s Femara (letrozole)...read more